{"id":"mifepristone-and-misoprostol","safety":{"commonSideEffects":[{"rate":"95","effect":"Vaginal bleeding"},{"rate":"85","effect":"Abdominal pain/cramping"},{"rate":"50","effect":"Nausea"},{"rate":"25","effect":"Vomiting"},{"rate":"20","effect":"Diarrhea"},{"rate":"10","effect":"Headache"},{"rate":"10","effect":"Dizziness"}]},"_chembl":{"chemblId":"CHEMBL4064157","moleculeType":"Small molecule","molecularWeight":"382.54"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Mifepristone is a progesterone antagonist that prevents the hormone from maintaining the uterine lining and pregnancy. Misoprostol, a prostaglandin analog, is administered after mifepristone to induce uterine contractions and facilitate expulsion of pregnancy tissue. Together, they constitute a medical abortion regimen.","oneSentence":"Mifepristone blocks progesterone receptors to stop pregnancy development, while misoprostol causes uterine contractions to expel pregnancy tissue.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:55:17.555Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Medical abortion up to 10 weeks of gestation (or per regulatory approval in specific jurisdictions)"}]},"trialDetails":[{"nctId":"NCT05322252","phase":"PHASE4","title":"Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled Trial","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2022-07-01","conditions":"Abortion, Second Trimester, PPROM, Rupture, Spontaneous","enrollment":30},{"nctId":"NCT07422506","phase":"NA","title":"A Real-World Study Comparing the Efficacy of Different Treatment Regimens for Early Missed Abortion","status":"RECRUITING","sponsor":"The Third Xiangya Hospital of Central South University","startDate":"2024-01-01","conditions":"Missed Abortion, Early Pregnancy Failure","enrollment":580},{"nctId":"NCT07174856","phase":"PHASE4","title":"The Misoprostol-Only Regimen Evidence Study","status":"NOT_YET_RECRUITING","sponsor":"Ibis Reproductive Health","startDate":"2025-10-10","conditions":"Abortion, Medical","enrollment":1900},{"nctId":"NCT06456164","phase":"NA","title":"IntraCERvical Balloon Catheter in the Setting of Induction of Labor for Fetal Loss or Abortion","status":"WITHDRAWN","sponsor":"University of Chicago","startDate":"2025-02-01","conditions":"Abortion, Complete, Fetal Death, Induction of Labor Affected Fetus / Newborn","enrollment":""},{"nctId":"NCT04905251","phase":"","title":"Effectiveness and Safety of Combination Mifepristone/Misoprostol for Medical Abortion","status":"TERMINATED","sponsor":"Linepharma International LTD","startDate":"2022-02-19","conditions":"Medical Abortion","enrollment":129},{"nctId":"NCT06733727","phase":"NA","title":"Letrozole Versus Mifepristone and Misoprostol in Silent Miscarriage","status":"NOT_YET_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2024-12-06","conditions":"Silent Miscarriage","enrollment":884},{"nctId":"NCT03913104","phase":"PHASE4","title":"Mail Order Mifepristone Study","status":"COMPLETED","sponsor":"Daniel Grossman, MD","startDate":"2020-01-05","conditions":"Abortion Early, Pregnancy Related","enrollment":536},{"nctId":"NCT05097326","phase":"PHASE3","title":"Mifepristone for Labor Induction","status":"COMPLETED","sponsor":"Stanford University","startDate":"2022-06-27","conditions":"Induced Vaginal Delivery","enrollment":30},{"nctId":"NCT01862991","phase":"NA","title":"Pre-Operative Effects of Mifepristone on Dilation and Evacuation Services","status":"COMPLETED","sponsor":"Stanford University","startDate":"2013-07","conditions":"Legally Induced Abortion Without Mention of Complication","enrollment":80},{"nctId":"NCT01615731","phase":"NA","title":"Value of Mifepristone in Cervical Preparation Prior to Dilation and Evacuation 19-24 Weeks","status":"COMPLETED","sponsor":"Stanford University","startDate":"2012-05","conditions":"Abortion, Induced","enrollment":50},{"nctId":"NCT05304273","phase":"PHASE3","title":"Comparison Between Letrozole and Mifepristone in Medical Termination of First Trimester Miscarriages","status":"UNKNOWN","sponsor":"Calcutta National Medical College and Hospital","startDate":"2022-05-05","conditions":"Miscarriage","enrollment":120},{"nctId":"NCT05839899","phase":"PHASE3","title":"Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location","status":"UNKNOWN","sponsor":"Planned Parenthood League of Massachusetts","startDate":"2023-08-30","conditions":"Abortion","enrollment":50},{"nctId":"NCT04751500","phase":"NA","title":"The HYsteroscopic Miscarriage MaNagement Trial: A Pilot RCT Investigating a Novel Management Pathway for RPOC","status":"COMPLETED","sponsor":"Birmingham Women's and Children's NHS Foundation Trust","startDate":"2021-01-31","conditions":"Retained Products After Miscarriage","enrollment":149},{"nctId":"NCT05119439","phase":"PHASE4","title":"Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks","status":"TERMINATED","sponsor":"Gynuity Health Projects","startDate":"2022-10-07","conditions":"Medical Abortion","enrollment":23},{"nctId":"NCT04941443","phase":"PHASE4","title":"Methadone and Medication Abortion","status":"TERMINATED","sponsor":"Boston Medical Center","startDate":"2021-10-04","conditions":"Pain, Medical Abortion","enrollment":4},{"nctId":"NCT03440866","phase":"NA","title":"Comparison of the Effectiveness of Treatment With Mifepristone and Misoprostol at the Same Time Compared to the Administration of Drugs at a 48-hour Interval for Medical Abortion.","status":"UNKNOWN","sponsor":"HaEmek Medical Center, Israel","startDate":"2018-03-01","conditions":"Early Pregnancy","enrollment":250},{"nctId":"NCT03043014","phase":"NA","title":"Cervical Preparation of Abortions Under Paracervical Block in the First Trimester:","status":"COMPLETED","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2017-06-01","conditions":"Surgical Abortion","enrollment":110},{"nctId":"NCT02412618","phase":"PHASE4","title":"Same-Day Mifepristone-Misoprostol Compared to Misoprostol Only for Surgical Abortion Cervical Preparation","status":"COMPLETED","sponsor":"Medstar Health Research Institute","startDate":"2012-09","conditions":"Induced Abortion","enrollment":100},{"nctId":"NCT05124314","phase":"PHASE4","title":"Comparison of Two Different Drug Regimens for Medical Treatment of Early Pregnancy Loss","status":"UNKNOWN","sponsor":"Clinical Hospital Merkur","startDate":"2021-10-27","conditions":"Abortion, Missed","enrollment":220},{"nctId":"NCT05046041","phase":"PHASE4","title":"Assessing Outpatient 'Day Procedure' for Second-trimester Medical Abortion at Two Public Sector Hospitals in Nepal","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2020-11-25","conditions":"Abortion in Second Trimester","enrollment":120},{"nctId":"NCT02704481","phase":"PHASE4","title":"Non-surgical Alternatives to Treatment of Failed Medical Abortion","status":"TERMINATED","sponsor":"Gynuity Health Projects","startDate":"2016-06-01","conditions":"Abortion Failure","enrollment":16},{"nctId":"NCT04063904","phase":"PHASE4","title":"Pilot Study of an Ambulatory Medical Abortion Service at 13-18 Weeks of Gestation in Colombia","status":"TERMINATED","sponsor":"Gynuity Health Projects","startDate":"2019-10-16","conditions":"Second Trimester Abortion","enrollment":16},{"nctId":"NCT03320057","phase":"PHASE4","title":"Medication Abortion Via Pharmacy Dispensing","status":"COMPLETED","sponsor":"Daniel Grossman","startDate":"2018-06-01","conditions":"Pregnancy Related, Abortion Early","enrollment":326},{"nctId":"NCT03972358","phase":"PHASE2","title":"Assessing Medical Menstrual Regulation in the United States","status":"UNKNOWN","sponsor":"Gynuity Health Projects","startDate":"2020-02-12","conditions":"Menstrual Regulation","enrollment":284},{"nctId":"NCT04602052","phase":"NA","title":"Comparison of Surgical Versus Medical Termination of Pregnancy Between 13-20 Weeks of Gestation in Ethiopia","status":"COMPLETED","sponsor":"St. Paul's Hospital Millennium Medical College, Ethiopia","startDate":"2018-11-01","conditions":"Termination of Pregnancy","enrollment":279},{"nctId":"NCT03212352","phase":"PHASE4","title":"Comparing Two Medical Treatments for Early Pregnancy Failure.","status":"TERMINATED","sponsor":"Radboud University Medical Center","startDate":"2018-06-27","conditions":"Early Pregnancy Failure","enrollment":342},{"nctId":"NCT03065660","phase":"PHASE3","title":"Mifepristone and Misoprostol Versus Misoprostol Alone in the Medical Management of Missed Miscarriage","status":"COMPLETED","sponsor":"University of Birmingham","startDate":"2017-09-20","conditions":"Missed Miscarriage","enrollment":711},{"nctId":"NCT02679092","phase":"NA","title":"Mifepristone Versus Osmotic Dilators in Conjunction With Misoprostol for Cervical Preparation Prior to D&E at 14-19 Weeks","status":"WITHDRAWN","sponsor":"Stanford University","startDate":"2016-04","conditions":"Legally Induced Abortion Without Mention of Complication","enrollment":""},{"nctId":"NCT03829696","phase":"PHASE4","title":"Advance Provision of Medication Abortion","status":"WITHDRAWN","sponsor":"University of California, San Francisco","startDate":"2020-01","conditions":"Early Abortion","enrollment":""},{"nctId":"NCT03269279","phase":"PHASE3","title":"Mifepristone and Misoprostol for 2nd Trimester Termination of Pregnancy in Burkina Faso","status":"UNKNOWN","sponsor":"Gynuity Health Projects","startDate":"2017-05-20","conditions":"Medical; Abortion, Fetus","enrollment":100},{"nctId":"NCT03346629","phase":"PHASE4","title":"Outpatient Service for Mid-trimester Termination of Pregnancy","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2017-12-01","conditions":"Abortion in Second Trimester","enrollment":230},{"nctId":"NCT02633761","phase":"PHASE3","title":"Mifepristone-misoprostol vs. Misoprostol Alone for Second Trimester Fetal Death","status":"TERMINATED","sponsor":"Gynuity Health Projects","startDate":"2015-04-01","conditions":"Fetal Death","enrollment":200},{"nctId":"NCT02342002","phase":"PHASE4","title":"Mifepristone and Misoprostol Versus Misoprostol Alone for Missed Abortion: A Randomized-controlled Trial","status":"TERMINATED","sponsor":"Gynuity Health Projects","startDate":"2015-01","conditions":"Missed Abortion, Pregnancy","enrollment":416},{"nctId":"NCT03134183","phase":"PHASE4","title":"24-hour Mifepristone and Buccal Versus Mifepristone and Vaginal Misoprostol for Cervical Preparation for D&E","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2016-11-19","conditions":"Abortion, Second Trimester","enrollment":70},{"nctId":"NCT02981030","phase":"PHASE4","title":"Acceptability and Feasibility of a Simplified Medical Abortion Service Delivery in Western Ukraine","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2016-11-23","conditions":"Abortion, Therapeutic","enrollment":102},{"nctId":"NCT02985229","phase":"PHASE3","title":"Acceptability and Feasibility of Medical Abortion in Singapore","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2016-10","conditions":"Medical Abortion","enrollment":130},{"nctId":"NCT00592215","phase":"PHASE1","title":"Second Trimester Labor Induction","status":"WITHDRAWN","sponsor":"Johns Hopkins University","startDate":"2008-03","conditions":"Second Trimester Labor Induction","enrollment":""},{"nctId":"NCT03248050","phase":"NA","title":"Evaluating an Intervention to Increase Use of Call Centre Support for Self-managed Medical Abortion","status":"UNKNOWN","sponsor":"Marie Stopes International","startDate":"2017-10-15","conditions":"Abortion, Drug-Induced, Pharmacies","enrollment":1359},{"nctId":"NCT02570204","phase":"NA","title":"Self-Assessment of Medical Abortion Outcome Using Serial Multi-level Pregnancy Tests","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2015-09","conditions":"Medical Abortion","enrollment":343},{"nctId":"NCT03044093","phase":"PHASE4","title":"Mifepristone and Misoprostol Compared With Misoprostol Alone for Second Trimester Abortion","status":"UNKNOWN","sponsor":"Rambam Health Care Campus","startDate":"2017-01","conditions":"Second Trimester Abortion","enrollment":200},{"nctId":"NCT02415894","phase":"","title":"Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in Ukraine","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2015-04","conditions":"Other Abortion","enrollment":172},{"nctId":"NCT02708446","phase":"PHASE4","title":"A Comparison of Sublingual and Buccal Misoprostol Regimens After Mifepristone for Mid-trimester Abortion","status":"UNKNOWN","sponsor":"Gynuity Health Projects","startDate":"2014-05","conditions":"Legally Induced Abortion Without Mention of Complication","enrollment":320},{"nctId":"NCT02314754","phase":"PHASE4","title":"Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2014-12","conditions":"Medical Abortion","enrollment":719},{"nctId":"NCT02745093","phase":"PHASE4","title":"Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks","status":"UNKNOWN","sponsor":"Ibis Reproductive Health","startDate":"2016-09","conditions":"Medical Abortion","enrollment":648},{"nctId":"NCT02720991","phase":"PHASE4","title":"A Pilot of an Outpatient Regimen of Medical Abortion With Mifepristone and Sublingual Misoprostol in the 11 and 12 Weeks","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2014-07","conditions":"Abortion, 3 Months","enrollment":50},{"nctId":"NCT01751087","phase":"NA","title":"Cervical Preparation Before Dilation and Evacuation","status":"COMPLETED","sponsor":"Planned Parenthood League of Massachusetts","startDate":"2013-01","conditions":"Abortion, Induced","enrollment":300},{"nctId":"NCT00269568","phase":"PHASE4","title":"Mifepristone at Same Time Multicenter Study","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2004-06","conditions":"Abortion Seekers","enrollment":1128},{"nctId":"NCT00177372","phase":"PHASE4","title":"Mifepristone and Misoprostol for Fetal Demise","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2005-01","conditions":"Anembryonic Pregnancy, Gestation Abnormality, Intrauterine Fetal Demise Term","enrollment":30},{"nctId":"NCT00619658","phase":"NA","title":"The Feasibility of Simplified Telephone Follow-up After Medical Abortion","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2008-02","conditions":"Induced Abortion","enrollment":139},{"nctId":"NCT02235155","phase":"","title":"Mifepristone and Misoprostol for Midtrimester Termination of Pregnancy in Uzbekistan","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2014-09","conditions":"Abortion in Second Trimester","enrollment":135},{"nctId":"NCT01798017","phase":"PHASE4","title":"Introducing Mifepristone-Misoprostol for Menstrual Regulation in Public Sector Facilities in Bangladesh","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2012-11","conditions":"Menstrual Regulation","enrollment":1738},{"nctId":"NCT02018796","phase":"","title":"Mifepristone and Misoprostol for the Termination of Pregnancy up to 70 Days' Gestation in Kazakhstan","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2013-10","conditions":"Complete Abortion","enrollment":290},{"nctId":"NCT01615211","phase":"PHASE2","title":"Randomized Study of Letrozole and Trilostane for Medical Abortion","status":"TERMINATED","sponsor":"Kristina Gemzell Danielsson","startDate":"2012-05","conditions":"Medical Abortion, Complete or Unspecified, Without Complication","enrollment":36},{"nctId":"NCT02398838","phase":"NA","title":"Acceptability and Feasibility of a Simplified Medical Abortion Regimen in Georgia","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2009-12","conditions":"Abortion, First Trimester","enrollment":622},{"nctId":"NCT01795599","phase":"PHASE3","title":"Cervical Preparation for Surgical Abortion at 12-14 Weeks: a Prospective, Randomized, Evaluator-blinded, Multicenter, Controlled Comparison Between Mifepristone, Misoprostol and Their Combination","status":"UNKNOWN","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2013-05","conditions":"Surgical Abortion","enrollment":198},{"nctId":"NCT01827995","phase":"PHASE4","title":"Simplified Medical Abortion in Rural India","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2013-04","conditions":"Pregnancy","enrollment":731},{"nctId":"NCT00386282","phase":"NA","title":"Acceptability and Feasibility of Medical Abortion Using Mifepristone and Buccal Misoprostol","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2006-09","conditions":"Abortion, First Trimester","enrollment":1250},{"nctId":"NCT01766388","phase":"","title":"Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in Armenia","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2012-12","conditions":"Abortion in Second Trimester","enrollment":120},{"nctId":"NCT01768299","phase":"PHASE4","title":"Medical Abortion With Mifepristone + Misoprostol (13 - 22 Weeks)","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2013-02","conditions":"Complete Uterine Evacuation After Use of Study Drugs","enrollment":504},{"nctId":"NCT00969982","phase":"NA","title":"Mifepristone Plus Misoprostol Versus Misoprostol Alone for 2nd Trimester Abortion (14 - 21 Weeks Last Menstrual Period (LMP))","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2009-06","conditions":"Abortion, Induced","enrollment":238},{"nctId":"NCT00784186","phase":"NA","title":"Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14 - 21 Weeks LMP): A Randomized-controlled Double-blinded Trial","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2008-08","conditions":"Abortion, Induced","enrollment":120},{"nctId":"NCT01966874","phase":"","title":"Mifepristone and Misoprostol for the Termination of Pregnancy up to 70 Days Gestation","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2011-08","conditions":"Medical; Abortion, Fetus","enrollment":1001},{"nctId":"NCT01856985","phase":"PHASE4","title":"Acceptability of an Out-patient Regimen of Medical Abortion With Mifepristone and 800 Mcg Misoprostol Administered at 78-84 Days Gestation","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2013-04","conditions":"Medical Abortion","enrollment":50},{"nctId":"NCT01487213","phase":"NA","title":"Routine Follow-up Versus Self-assessment in Medical Abortion","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2011-09","conditions":"Medical Abortion","enrollment":929},{"nctId":"NCT00864799","phase":"NA","title":"Techniques to Improve Efficacy of Second Trimester Medical Termination","status":"COMPLETED","sponsor":"King Edward Memorial Hospital","startDate":"2009-04","conditions":"Pregnancy","enrollment":302},{"nctId":"NCT01410266","phase":"PHASE4","title":"Reducing the Need for In-Clinic Follow-Up for Medical Abortion in Moldova and Uzbekistan","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2010-09","conditions":"Medical Abortion, Fetus","enrollment":2400},{"nctId":"NCT00997347","phase":"PHASE4","title":"The Extended Gestational Age Medical Abortion Study","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2009-07","conditions":"Medical Abortion","enrollment":1400},{"nctId":"NCT00997074","phase":"PHASE3","title":"Efficacy Study of Prophylactic Ibuprofen Versus Placebo on Pain Relief and Success Rates of Medical Abortion","status":"COMPLETED","sponsor":"Sheba Medical Center","startDate":"2009-10","conditions":"Pain, Pregnancy","enrollment":61},{"nctId":"NCT01475318","phase":"NA","title":"Study on Combined Use of Letrozole, Mifepristone and Misoprostol in Termination of Pregnancy","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2011-10","conditions":"Complete Abortion","enrollment":50},{"nctId":"NCT00957346","phase":"PHASE3","title":"Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14-21 Weeks LMP)","status":"TERMINATED","sponsor":"Gynuity Health Projects","startDate":"2011-02","conditions":"Abortion, Induced","enrollment":20},{"nctId":"NCT00468299","phase":"NA","title":"MiMi: A Randomized Trial of Mifepristone and Misoprostol for Treatment of Early Pregnancy Failure","status":"TERMINATED","sponsor":"Boston University","startDate":"2007-04","conditions":"Early Pregnancy Failure, Miscarriage, Fetal Demise","enrollment":16},{"nctId":"NCT00920465","phase":"PHASE3","title":"Treatment Regimens for Mifegyne and Cytotec","status":"UNKNOWN","sponsor":"Western Galilee Hospital-Nahariya","startDate":"2009-06","conditions":"Medical Abortion","enrollment":200},{"nctId":"NCT00190294","phase":"PHASE4","title":"Expectant Versus Immediate Medical Management for the Evacuation of the no Evolutionary Pregnancies Before 13 GW","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2003-04","conditions":"Pregnancy Complications","enrollment":200},{"nctId":"NCT00945997","phase":"NA","title":"Misoprostol for Second Trimester Termination of Pregnancy","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2000-10","conditions":"Termination of Pregnancy Second Trimester","enrollment":176},{"nctId":"NCT00870272","phase":"NA","title":"Study of 400mcg Sublingual Versus 400mcg Buccal Misoprostol Following 200mg Mifepristone for Medical Abortion up to 63 Days Last Menstrual Period (LMP)","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2007-07","conditions":"Abortion, Induced","enrollment":550},{"nctId":"NCT00677755","phase":"NA","title":"Medical Abortion for Emergency Contraception Failure","status":"COMPLETED","sponsor":"Taizhou Hospital","startDate":"2004-10","conditions":"Emergency Contraception, Abortion, Induced","enrollment":394},{"nctId":"NCT00206193","phase":"","title":"Termination of Pregnancy With Mifepristone and Misoprostol Versus Sulprostone","status":"UNKNOWN","sponsor":"Atrium Medical Center","startDate":"","conditions":"Abortion, Induced","enrollment":""},{"nctId":"NCT00330993","phase":"PHASE2","title":"Oral Mifepristone and Buccal Misoprostol Administered Simultaneously for Abortion Through 63 Days Gestation","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2006-03","conditions":"Abortion, Induced","enrollment":120}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":488,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Mifepristone and misoprostol","genericName":"Mifepristone and misoprostol","companyName":"Gynuity Health Projects","companyId":"gynuity-health-projects","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Mifepristone blocks progesterone receptors to stop pregnancy development, while misoprostol causes uterine contractions to expel pregnancy tissue. Used for Medical abortion up to 10 weeks of gestation (or per regulatory approval in specific jurisdictions).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}